Compare Agilent Technologies Inc (A) vs Nvidia Corp (NVDA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Nvidia Corp — how do they compare? Agilent Technologies Inc trades at $128.24 (market cap $37.04B), while Nvidia Corp trades at $199.35 (market cap $4.77T). The key difference: Nvidia Corp is far larger — about 128.8× Agilent Technologies Inc's market cap, and Agilent Technologies Inc pays the higher dividend (0.78%). Which is the better fit depends on your goals.
| A | NVDA | |
|---|---|---|
Market Cap | $37.04B | $4.77T |
Sector | Health | Technology |
52-Week High | $157.20 | $235.75 |
52-Week Low | $110.24 | $160.00 |
Enterprise Value | $38.59B | $4.70T |
Dividend Yield | 0.78% | 0.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
NVIDIA (NVDA) trades at $197.62, up 1.06% on the day, with technical indicators showing a bearish bias despite recent earnings beats. The company demonstrates exceptional fundamental strength with revenue surging to $130.5B in 2025 and net profit margins expanding to 55.84%. Analyst consensus remains strongly bullish with a $324.95 price target, representing significant upside potential from current levels.
NVIDIA's outlook is supported by dominant AI chip positioning and accelerating revenue growth, though risks include increased competition, peak AI infrastructure spending concerns, and rich valuations. The stock presents a compelling growth opportunity for investors comfortable with technology sector volatility and premium valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
